The Journal of Immunology, Vol 150, Issue 3 940-949, Copyright © 1993 by American Association of Immunologists

ARTICLES

Schistosoma mansoni 28-kDa glutathione S-transferase and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domains

CB Xu, C Verwaerde, H Gras-Masse, J Fontaine, M Bossus, F Trottein, I Wolowczuk, A Tartar and A Capron
Centre d'Immunologie et de Biologie Parasitaire, Unite INSERM 167-CNRS 624, Institut Pasteur, Lille, France.

We have previously shown that a mAb that inhibits the enzymatic activity of the Schistosoma mansoni 28-kDa glutathione S-transferase (Sm28 GST) also reduces female worm fecundity and egg viability in vivo and in vitro. By peptidic epitope mapping and an activity reconstitution assay, the carboxyl terminus (CT) amino acid residues 190-211 and to a lesser extent the truncated amino terminus (NT) residues 10-43 of the enzyme were identified as mAb recognition sites. Sera from rats immunized with the NT (10-43) and CT (190-211) peptides showed a partial inhibitory effect on Sm28 GST activity in a late phase (6 to 7 wk) but not in an early phase (2 to 4 wk) after immunization. Passive transfer of Sm28 GST-inhibiting anti-N- and C-terminal sera, but not of the noninhibitory sera, protected the infected mice by reducing tissue egg deposition and the ability of eggs to hatch. In active immunization experiments, the CT peptide significantly decreased the worm burden (37 to 40%) in mice as did the rSm28 GST (28 to 52%). In terms of tissue egg deposition and egg-hatching ability, immunization with both the NT and CT peptides reproduced the reduction observed after immunization with rSm28 GST. A constant reduction in egg numbers was noted in the small intestines and the livers of the immunized mice. A clear reduction in the ability of intestinal or hepatic eggs to hatch was observed. The results are discussed in terms of the conformational participation of the NT and CT of Sm28 in the expression of GST activity.

This article has been cited by other articles:

				D. P. McManus and A. Loukas Current Status of Vaccines for Schistosomiasis Clin. Microbiol. Rev., January 1, 2008; 21(1): 225 - 242. [Abstract] [Full Text] [PDF]

				A. Capron, M. Capron, and G. Riveau Vaccine development against schistosomiasis from concepts to clinical trials Br. Med. Bull., July 1, 2002; 62(1): 139 - 148. [Abstract] [Full Text] [PDF]

				F. Remoue, J.-C. Mani, M. Pugniere, A.-M. Schacht, A. Capron, and G. Riveau Functional Specific Binding of Testosterone to Schistosoma haematobium 28-Kilodalton Glutathione S-Transferase Infect. Immun., February 1, 2002; 70(2): 601 - 605. [Abstract] [Full Text] [PDF]

				J.-B. Sun, N. Mielcarek, M. Lakew, J.-M. Grzych, A. Capron, J. Holmgren, and C. Czerkinsky Intranasal Administration of a Schistosoma mansoni Glutathione S-Transferase-Cholera Toxoid Conjugate Vaccine Evokes Antiparasitic and Antipathological Immunity in Mice J. Immunol., July 15, 1999; 163(2): 1045 - 1052. [Abstract] [Full Text] [PDF]

				J.-M. Grzych, J. De Bont, J. Liu, J.-L. Neyrinck, J. Fontaine, J. Vercruysse, and A. Capron Relationship of Impairment of Schistosome 28-Kilodalton Glutathione S-Transferase (GST) Activity to Expression of Immunity to Schistosoma mattheei in Calves Vaccinated with Recombinant Schistosoma bovis 28-Kilodalton GST Infect. Immun., March 1, 1998; 66(3): 1142 - 1148. [Abstract] [Full Text] [PDF]

				L. K. Arruda, L. D. Vailes, T. A. E. Platts-Mills, M. L. Hayden, and M. D. Chapman Induction of IgE Antibody Responses by Glutathione S-Transferase from the German Cockroach (Blattella germanica) J. Biol. Chem., August 15, 1997; 272(33): 20907 - 20912. [Abstract] [Full Text] [PDF]